1. Applications for Oncologic Drugs: A Descriptive Analysis of the Oncologic Drugs Advisory Committee Reviews. (5th March 2014) Authors: Chan, John K.; Kiet, Tuyen K.; Monk, Bradley J.; Young‐Lin, Nichole; Blansit, Kevin; Kapp, Daniel S.; Amanam, Idoroenyi Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Applications for Oncologic Drugs: A Descriptive Analysis of the Oncologic Drugs Advisory Committee Reviews. (5th March 2014) Authors: Chan, John K.; Kiet, Tuyen K.; Monk, Bradley J.; Young-Lin, Nichole; Blansit, Kevin; Kapp, Daniel S.; Amanam, Idoroenyi Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Applying Artificial Intelligence to Gynecologic Oncology: A Review. Issue 5 (May 2021) Authors: Mysona, David Pierce; Kapp, Daniel S.; Rohatgi, Atharva; Lee, Danny; Mann, Amandeep K.; Tran, Paul; Tran, Lynn; She, Jin-Xiong; Chan, John K. Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Applying Artificial Intelligence to Gynecologic Oncology: A Review. Issue 5 (May 2021) Authors: Mysona, David Pierce; Kapp, Daniel S.; Rohatgi, Atharva; Lee, Danny; Mann, Amandeep K.; Tran, Paul; Tran, Lynn; She, Jin-Xiong; Chan, John K. Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 5(2021) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab in Treatment of High-Risk Ovarian Cancer—A Cost-Effectiveness Analysis. (10th April 2014) Authors: Chan, John K.; Herzog, Thomas J.; Hu, Lilian; Monk, Bradley J.; Kiet, Tuyen; Blansit, Kevin; Kapp, Daniel S.; Yu, Xinhua Journal: Oncologist Issue: Volume 19:Number 5(2014) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bevacizumab in Treatment of High‐Risk Ovarian Cancer—A Cost‐Effectiveness Analysis. (10th April 2014) Authors: Chan, John K.; Herzog, Thomas J.; Hu, Lilian; Monk, Bradley J.; Kiet, Tuyen; Blansit, Kevin; Kapp, Daniel S.; Yu, Xinhua Journal: Oncologist Issue: Volume 19:Number 5(2014) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Disparities Associated With Inpatient Palliative Care Utilization by Patients With Metastatic Gynecologic Cancers: A Study of 3337 Women. (April 2018) Authors: Rosenfeld, Emily B.; Chan, John K.; Gardner, Austin B.; Curry, Natasha; Delic, Lejla; Kapp, Daniel S. Journal: American journal of hospice & palliative care Issue: Volume 35:Number 4(2018) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Factors associated with oophorectomy in children with benign ovarian masses1. Issue 3 (3rd July 2017) Authors: Kapp, Daniel S.; Rosenfeld, Emily B.; Chan, Joshua E.; Chan, John K. Journal: International journal of gynaecology and obstetrics Issue: Volume 138:Issue 3(2017) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Gemogenovatucel-T (Vigil) Immunotherapy as Maintenance in Frontline Stage III/IV Ovarian Cancer (VITAL): A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial. Issue 3 (March 2021) Authors: Rocconi, Rodney P.; Grosen, Elizabeth A.; Ghamande, Sharad A.; Chan, John K.; Barve, Minal A.; Oh, Jonathan; Tewari, Devansu; Morris, Peter C.; Stevens, Erin E.; Bottsford-Miller, Justin N.; Tang, Min; Aaron, Phylicia; Stanbery, Laura; Horvath, Staci; Wallraven, Gladice; Bognar, Ernest; Manning, ... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Gemogenovatucel-T (Vigil) Immunotherapy as Maintenance in Frontline Stage III/IV Ovarian Cancer (VITAL): A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial. Issue 3 (March 2021) Authors: Rocconi, Rodney P.; Grosen, Elizabeth A.; Ghamande, Sharad A.; Chan, John K.; Barve, Minal A.; Oh, Jonathan; Tewari, Devansu; Morris, Peter C.; Stevens, Erin E.; Bottsford-Miller, Justin N.; Tang, Min; Aaron, Phylicia; Stanbery, Laura; Horvath, Staci; Wallraven, Gladice; Bognar, Ernest; Manning, ... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 3(2021) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗